An essential guide to prostate screening: real benefits, hidden risks, false positives, overdiagnosis, and tools for shared ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

NeoGenomics launched PTEN IHC CDx, the first IHC companion diagnostic test approved by the U.S. FDA for patients with prostate adenocarcinoma.

Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...

Prostate health awareness helps men identify early signs, understand risks, and navigate PSA tests and screening with trusted guidance.

An estimated 1 in 8 men will be diagnosed with prostate cancer in their lifetime, often after 65. And as terrifying as that number is, a diagnosis isn’t always quite what it seems. Today, the vast ...

Prostate cancer is increasingly diagnosed in younger Indian men, requiring early screening. Lifestyle and genetic factors ...

President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing forms is lacking.

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...